ATRENEW INC (RERE)

US00138L1089 - ADR

2.715  -0.12 (-4.06%)

Fundamental Rating

4

RERE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 125 industry peers in the Specialty Retail industry. No worries on liquidiy or solvency for RERE as it has an excellent financial health rating, but there are worries on the profitability. RERE shows excellent growth, but is valued quite expensive already.



1

1. Profitability

1.1 Basic Checks

RERE had negative earnings in the past year.
RERE had negative earnings in each of the past 5 years.
RERE had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -2.84%, RERE is in line with its industry, outperforming 42.40% of the companies in the same industry.
RERE has a Return On Equity (-4.21%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -2.84%
ROE -4.21%
ROIC N/A
ROA(3y)-23.13%
ROA(5y)-27.29%
ROE(3y)-29.48%
ROE(5y)-36.06%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

RERE's Gross Margin of 11.59% is on the low side compared to the rest of the industry. RERE is outperformed by 90.40% of its industry peers.
RERE's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for RERE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 11.59%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.06%
GM growth 5Y28.93%

7

2. Health

2.1 Basic Checks

RERE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RERE has been reduced compared to 1 year ago.
RERE has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, RERE has a worse debt to assets ratio.

2.2 Solvency

RERE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC7.86%

2.3 Liquidity

A Current Ratio of 2.68 indicates that RERE has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.68, RERE belongs to the top of the industry, outperforming 92.80% of the companies in the same industry.
A Quick Ratio of 2.07 indicates that RERE has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.07, RERE belongs to the top of the industry, outperforming 91.20% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.68
Quick Ratio 2.07

7

3. Growth

3.1 Past

RERE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 93.67%, which is quite impressive.
RERE shows a strong growth in Revenue. In the last year, the Revenue has grown by 31.37%.
Measured over the past years, RERE shows a very strong growth in Revenue. The Revenue has been growing by 31.79% on average per year.
EPS 1Y (TTM)93.67%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q100.13%
Revenue 1Y (TTM)31.37%
Revenue growth 3Y38.71%
Revenue growth 5Y31.79%
Revenue growth Q2Q29.93%

3.2 Future

Based on estimates for the next years, RERE will show a very strong growth in Earnings Per Share. The EPS will grow by 88.77% on average per year.
The Revenue is expected to grow by 25.75% on average over the next years. This is a very strong growth
EPS Next Y19.81%
EPS Next 2Y88.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year24.74%
Revenue Next 2Y25.75%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RERE. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 20.85 indicates a rather expensive valuation of RERE.
The rest of the industry has a similar Price/Forward Earnings ratio as RERE.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.15, RERE is valued at the same level.
Industry RankSector Rank
PE N/A
Fwd PE 20.85

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
RERE's earnings are expected to grow with 88.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y88.77%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for RERE!.
Industry RankSector Rank
Dividend Yield N/A

ATRENEW INC

NYSE:RERE (5/20/2024, 10:42:09 AM)

2.715

-0.12 (-4.06%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap601.92M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 20.85
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.84%
ROE -4.21%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 11.59%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.36
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.68
Quick Ratio 2.07
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)93.67%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y19.81%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)31.37%
Revenue growth 3Y38.71%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y